An official website of the United States government
Here's how you know
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Artificial intelligence makes its way to MacDill dermatology clinic

  • Published
  • By Senior Airman Adam R. Shanks
  • 6th Air Refueling Wing Public Affairs
The dermatology clinic at MacDill Air Force Base boasts a machine that can help patients log and track various skin conditions over time.

The software's ability to use high resolution photos of the patients’ body and intelligently detect when new marks appear and grow larger allows Maj. Thomas Beachkofsky, the 6th Health Care Operations Squadron dermatologist, easily to monitor areas of concern with his patients.

However, a new software upgrade that takes advantage of machine learning has opened up new opportunities to use this machine, which is one of two in the Air Force.

“Our new software that works with our body scanner uses artificial intelligence and machine learning to analyze a lesion or mark on the skin and uses an algorithm to rate the likelihood that the spot is harmful,” said Beachkofsky. “With training, our dermatology technicians can use this program to efficiently scan and process questionable spots.”

Beachkofsky explained that although the machine makes an educated guess on the severity of the lesion, it is up to a fully-trained dermatologist to make a diagnosis and recommend treatment.

Lt. Col. Kurtis Kobes, the 6th Operational Medical Readiness Squadron dental flight commander, was among the first to benefit from the new software, after seeking a second glance at MacDill’s clinic for a spot on his forearm.

“Based on how it looked, and the results from the scan, I ordered a biopsy which came back as melanoma in situ,” remarked Beachkofsky.

Melanoma in situ, also called stage zero melanoma, is a very early stage of cancer where the cancerous cells only affect the epidermis and have not spread to deeper layers of the skin.

“It’s very fortunate that something like this was caught in as early of a stage as it did,” remarked Beachkofsky. “Melanoma can be deadly if left to spread, so treating it while it’s in situ allows a simple procedure with a fast recovery.”

With the new software upgrade, the dermatology office hopes to give its patients the peace of mind that their questionable spots can be checked accurately and efficiently.

“I’m very grateful for the dermatology clinic quickly verifying and handling the suspicious area on my forearm,” said Kobes. “I’ve had this spot for over a year, and after having it looked at by other clinics, I was only told it could be monitored, but it didn’t look alarming.”

In a study named “Man against machine,” the deep-learning algorithm used by the analyzing software was able to correctly identify 95% of malignant skin tumors. This data was compared to 58 dermatologists across 17 nations, who were able to successfully identify 86.6% of the same tumors.

“It’s definitely not a replacement for doctors, nor is AI taking over health care,” laughed Beachkofsky. “It’s mostly a tool for a dermatologist to get a second opinion from a system that has analyzed tens of thousands of lesions and is constantly learning.”